PlasmaTech Biopharmaceuticals, Inc. PTBI
We were on top of PTBI in yesterday morning’s premarket report, catching it off of our scanner after an interesting PR alluded to activist investor George Soros taking up a position in the company. We also identified the attractiveness of the chart, and went so far as to say: “we like its chances of making a nice run.” Our expectations were exceeded roundly, and we actually ended up seeing a terrific run!
From an early low of 4.33 the stock surged to an impressive daily high of 7.77, carving out a 79% intraday rip on the chart. For a NASDAQ-listed $4.00+ stock, that is an incredible single-session performance.
The stock is pushing to new highs here in the premarket, and has officially crossed over the 100%-gainer line in less than a 24-hour period.
Take a look at the video chart we’ve prepared outlining PTBI’s epic performance so far:
Today’s continued momentum can likely be attributed to another PR out this morning, this time referring to a new acquisition. We’d suggest our readers follow the link to that press, included below. We’ll be actively monitoring this stock as we cruise through this midweek.
- PlasmaTech Biopharmaceuticals Announces Agreement to Acquire Abeona Therapeutics LLC (Wed 6:03AM EDT)
FATE, BRDR, ICLD, PBR PWE, MGI